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Hypertension Awareness, Treatment, and Control in Mexico: 
An Opportunistic Medical Student-led Blood Pressure 
Screening Campaign – A Cross-Sectional Study 
José Adrián Yamamoto-Moreno,1 Suzzette Anaís Navarro-Rodríguez,2 Samuel Ruiz-Pérez,3 Juan Carlos Godínez-Reyes,4 Marvin Mendoza-Rojo.5 
Abstract 
Background: Hypertension remains a growing public health concern in Mexico. This study aims to describe hypertension awareness, treatment, control, 
and its associated factors in participants of an opportunistic, medical student-led blood pressure screening campaign in Mexico. Methods: A cross-sectional 
study using convenience sampling was performed, including participants aged 18 years and older from 15 Mexican states. Each participant completed a 
questionnaire about risk factors and had three blood pressure measurements taken. Hypertension was defined as ≥140/90 mmHg. Multiple imputation 
with linear regression was performed where data was missing. Results: From a population of 2,545 participants, 623 (24.5%) participants had hypertension. 
Of those with hypertension, 81.9% had a previous diagnosis of hypertension, and only 16.1% were not on medication at the time of screening; 61% were 
controlled, 21% were uncontrolled patients, and 18% were not aware they had hypertension. The largest proportion of uncontrolled cases (33%) were 
found in states with high marginalization, and the number of unaware hypertensives in very low marginalization states were double that of the national 
figure. More than half of the participants taking antihypertensive agents were on a single medication, achieving control in almost 8 in 10 patients. 
Conclusion: Most uncontrolled hypertensive patients in Mexico belong to marginalized states. These results could inform state legislative policy to help 
bridge healthcare gaps. 
 




Hypertension is a chronic, controllable disease of multifactorial 
etiology, characterized by a sustained increase in blood pressure (BP) 
levels.1 Its importance lies in the fact that it is the most common risk 
factor for the development of cardiovascular disease (CVD), which is 
the leading cause of death worldwide, generating approximately 10.5 
million deaths per year.2,3 
 
In high-income countries, an improvement in the awareness, 
treatment, and control of the disease has been observed.4 Healthcare 
systems in countries with better control of hypertension such as the 
United States, Canada, South Korea, and Germany all have health 
education or health check-up programs.5 However, in low and middle-
income countries such as Brazil, China, India, Indonesia, Mexico, and 
South Africa, the results of disease prevention strategies have been less 
favorable, revealing a need to improve health services and prevention 
programs.6 
 
In Latin America, 40% of the adult population suffers from hypertension. 
This can be attributed to  considerable variations in hypertension 
awareness, treatment and control depending on race/ethnicity, sex, 
income, occupation, education, social position, psychosocial and 
behavioral factors, among other social aspects.7 For example, people 
with a higher socioeconomic level are more likely to be physically 
inactive, with physical inactivity being one of the main risk factors for 
hypertension.7 On the other hand, better adherence to treatment has 
been observed in people with a higher educational level.8 Small studies 
have shown that the majority of people living with hypertension do not 
know the normal BP levels and that there is a correlation between body 
weight and elevated BP.9 
 
Hypertension is still a growing public health concern in Mexico. The 
National Health and Nutrition Survey (ENSANUT) reported prevalence 
figures of 25.5%, of which 40.0% were not aware they had hypertension. 
Among those who were previously diagnosed with hypertension, 79.3% 
received pharmacological treatment, and only 45.6% were properly 
controlled.10 An estimated increase of 151% is expected in the number 
of individuals needing care for hypertension by 2050 if further actions 
are not taken in Mexico.8 
 
Several global campaigns have been devised to improve awareness and 
early detection of hypertension—such as the May Measurement Month 
(MMM)—a global screening intervention performed on an annual basis 
by the International Society of Hypertension (ISH). This campaign 
focuses on measuring BP among the general population and identifying 
risk and predisposing factors for the disease.3,6 The 2019 intervention 
had a response from more than 100 countries, with a final count of 
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As an approach to addressing such problems in Mexico, the Asociación 
Mexicana de Médicos en Formación (AMMEF, the Mexican Association 
of Physicians in Training) took the initiative to perform an opportunistic 
BP screening campaign inspired by the MMM methodology.3,6 The aim 
of this study was to describe hypertension awareness, treatment, 
control, and its associated factors in participants of an opportunistic 
medical student-led BP screening campaign in Mexico. 
 
Methods 
Study design and Participants 
This was a cross-sectional study using convenience sampling. A 
detailed protocol was developed to be used for all entities in the 
country. The full protocol can be consulted at 
http://ijms.info/IJMS/article/view/639/Supplementary_Material. The 
eligibility criteria for participants were an age of 18 years and older, 
and consent to participate in the study according to local policies. 
Online and face-to-face training was provided for leaders of local 
screening teams distributed in 15 states of Mexico about the 
questionnaire application and standardized methodology for BP 
measurements. The screening was performed in Aguascalientes, Baja 
California, Chihuahua, Chiapas, Coahuila, Durango, Guanajuato, México, 
Nayarit, Nuevo León, Puebla, San Luis Potosí, Sonora, Veracruz and 
Zacatecas. Sites of screening were set up in hospital waiting rooms, public 
outdoor or indoor areas, nursing homes, schools, homes, and workplaces.  
 
Data were collected from the beginning of June to the end of October 
2019 by volunteer medical students using an automated electronic 
device or an aneroid sphygmomanometer with a stethoscope. 
Recommendations for the measurement of BP included three seated 
recordings taken on the left (preferably) or right arm with a one-minute 
gap between readings. 
 
Questionnaire 
The MMM questionnaire was created by the International Society of 
Hypertension (ISH); it consisted of 24 items with sociodemographic 





Hypertension was defined as a systolic blood pressure (SBP) ≥140 
mmHg or a diastolic blood pressure (DBP) ≥90 mmHg in at least two of 
the readings. Cases were classified as “unaware hypertensive” (UAH) 
patients for those that satisfy the hypertension definition at screening 
but did not have a previous diagnosis or treatment; “controlled 
hypertensive” (CH) population for those with normal BP values at 
screening but with a previous diagnosis or treatment for hypertension; 
“uncontrolled hypertensive” (UCH) patients were those that complied 
hypertension criteria at screening and had a diagnosis and/or treatment 
for hypertension; “non-hypertensive” (NH) population were those that 
did not satisfy any of the previous conditions. A control group was 
established, including participants without hypertension who declared 
taking no medication or having clinical signs of diabetes, with no 
history of stroke, myocardial infarction (MI), gestational hypertension 
(GH), pregnancy at the time of screening, smoking, and alcohol 
drinking. Associated factors to changes in BP were considered to be 
fasting, history of stroke, history of MI, diabetes, pregnancy, history of 
GH, tobacco smoking, alcohol consumption, body mass index (BMI) and 
heart rate. Screening locations were classified according to Social Gap 
Index (SGI) emitted by the National Council for the Evaluation of Social 
Development Policy, which ranks federal entities on five levels based 
on access to education, health, basic services and housing, from lowest 
to highest level of social inequality.11 
 
According to the SGI, marginalization is very low in Aguascalientes, 
Coahuila and Nuevo León; low in Baja California, Chihuahua, State of 
Mexico, Sonora and Zacatecas; middle in Durango, Guanajuato and 
Nayarit; high in Puebla and San Luis Potosí and very high in Chiapas 
and Veracruz.11  
 
Statistical Analysis 
Multiple imputation with linear regression was performed five times 
using the missing at random (MAR) assumption where data was 
missing for variables such as height, weight, and subsequent BP 
readings. Geographical localization, sex, medical history, SBP, and DBP 
measurements were used as indicators for multiple imputation. Missing 
values were replaced with the pooled imputed data, and the resulting 
dataset was tested for normality using the Kolmogorov-Smirnov test in 
a Monte Carlo simulation of 500 cases. For the analysis of attributable 
factors to changes in BP, mean SBP, and DBP of the control group were 
calculated, and used as reference All statistical analysis was performed 




From a total of 2,549 entries, the study included 2,545 participants after 
eliminating 4 entries as shown in Figure 1. Missing data was observed 
in 48 (1.80%) cases for height, 52 (2.04%) for weight, 800 (31.43%) for 
second BP reading, and 1,320 (51.47%) for third BP reading. An 
estimated error <2% in data distribution was observed after multiple 
imputation.   
 





Roughly half of the screenings were carried out in open public areas 
(53.8%), followed by hospitals and clinics (26.8%), closed public areas 
(12.5%), homes (5.1%), workplaces (1.0%), educational institutions 
(0.5%) and nursing homes (0.3%). From the total number of participants 
included, 53.6% were women (see Table 1). Mean age was 41 years with 
a range from 18 to 91 years, with most participants in the 18 to 39 years 
age group, accounting for 50.6% of screened subjects. Almost a quarter 
(24.1%) of participants had a history of smoking, 57.7%declared having 
never or almost never consumed alcohol, 26.6% consumed alcohol 
between one and three times per month, and 15.3% at least once a 
week. Regarding diabetes, 6.9% of participants did not know if they had 
diabetes, whereas 11.4% declared having the diagnosis. Only 1.5% and 
2.7% of participants had a history of stroke or MI, respectively. A history 
of GH was declared by 9.2% of women involved, and only 40 (1.6%) 
participants were pregnant at the time of screening. 
 
The state with the most participants was Chiapas (12.9%), followed by 
Puebla (12.8%) and Sonora (11.9%). On the other hand, states with the 
smallest screened samples were San Luis Potosí (1.0%), Nuevo León 
(1.1%), and Zacatecas (2.0%). The highest mean BP standardized for 
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n = 1,922 
(75.5%) 
Total 
n = 2,545 
Sex, n (%) 
Male 303 (48.6%) 878 (45.7%) 1,181 (46.4%) 
Female 320 (51.4%) 1,044 (54.3%) 1,364 (53.6%) 
Age, years (standard deviation) 
Mean 56 (15) 36 (16) 41 (73) 
Range 18-90 18-91 18-91 
Age group, n (%) 
18 to 39 years 94 (15.1%) 1,195 (62.2%) 1,289 (50.6%) 
40 to 59 years 262 (42.1%) 531 (27.6%) 793 (31.2%) 
≥60 years 267 (42.9%) 196 (10.2%) 463 (18.2%) 
History of diabetes, n (%) 
Yes  173 (27.8%) 117 (6.1%) 290 (11.4%) 
No  399 (64%) 1,674 (87.1%) 2,073 (81.5%) 
Does not 
know 
51 (8.2%) 131 (6.9%) 133 (6.9%) 
History of smoking, n (%) 
Yes 163 (26.3%) 447 (23.4%) 610 (24.1%) 
No 456 (73.7%) 1,460 (76.6%) 1,916 (75.9%) 
Alcohol consumption, n (%) 
1 to 3 times 
per month 
132 (21.2%) 546 (28.4%) 678 (26.6%) 
At least once 
a week 
89 (14.3%) 301 (15.7%) 390 (15.3%) 
Never 401 (64.4%) 1,067 (55.5%) 1,468 (57.7%) 
Not declared 1 (0.2%) 8 (0.4%) 9 (0.4%) 
History of stroke, n (%) 
Yes 31 (5.1%) 6 (0.3%) 37 (1.5%) 
No 571 (94.9%) 1,886 (99.7%) 2,457 (98.5%) 
History of myocardial infarction, n (%) 
Yes 55 (9.2%) 13 (0.7%) 68 (2.7%) 
No 543 (90.8%) 1,884 (99.3%) 2,427 (97.3%) 
History of gestational pregnancy, n (%) 
Yes 73 (21.8%) 65 (5.6%) 138 (9.2%) 
No 262 (78.2%) 1,104 (94.4%) 1,366 (90.8%) 
Antihypertensive drugs usage, n (%) 
Yes 428 (68.7%) 0 (0.0%) 428 (68.7%) 
No 195 (31.7%) 0 (0.0%) 195 (31.7%) 
Aspirin usage, n (%) 
Yes 208 (33.5%) 244 (12.8%) 452 (17.9%) 
No 412 (66.5%) 1,666 (87.2%) 2,078 (82.1%) 
Statin usage, n (%) 
Yes 158 (25.5%) 38 (2%) 196 (7.8%) 
No 462 (74.5%) 1,866 (98%) 2,328 (92.2%) 
 
and the lowest that of Aguascalientes (SBP 110.75 mmHg, DBP 70.56 
mmHg), as shown in Table 2. Stratifying by the SGI, states with a low 
SGI had the most participants (33.7%), and those with very low SGI had 
least participation (11.2%). Mean BP standardized by age and sex was 
highest at high SGI (SBP 124.14 mmHg, DBP 82.29 mmHg) and lowest at 
Figure 2. Proportion of Unaware, Uncontrolled and Controlled Hypertensives 





low SGI (SBP 121.14 mmHg, 78.64 mmHg), as can be seen in Table 3. The 
number of identified cases of hypertension decreased by 1.25% and 
3.57% with the second and third readings, respectively, and increased 
to 5.18% using the mean of the three readings, as shown in Table 4. 
 
National mean BP, considering all three readings, was 119.56 mmHg for 
SBP and 77.28 for DBP. Classifying participants by type of case, as 
previously described, it was found that 922 (75.5%) were NH and 623 
(24.5%) participants had hypertension. Of those with hypertension, 510 
(81.9%) subjects had a previous diagnosis of hypertension, and only 82 
(16.1%) did not declare taking a pharmacological treatment at the time 
of screening; 397 (61%) were CH patients, 128 (21%) were UCH patients 
and 113 (18%) were UAH cases. The proportion of UAH patients in areas 
with a very high SGI was only 1% above the national figure; meanwhile 
those areas with a very low SGI doubled it (34% vs. 18%). States with a 
low SGI were the areas with the smallest number of cases of UAH (14%). 
A high SGI was found to have the highest number of UCH cases (33%), 
being the only group of states surpassing the national figure. On the 
other hand, areas with medium SGI had the largest proportion of CH 
cases (67%). In contrast, regions with a very low SGI had the smallest 
proportion of controlled patients, followed by the states with low SGI, 
13% and 9% below the national figure, respectively, as shown in Figure 2. 
 
The most common medications among participants were 
antihypertensive drugs, such as angiotensin-converting enzyme 
inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium 
channel blockers, diuretics, beta-blockers, and alpha-agonists, with 428 
(16.8%) patients taking at least one of them, which accounted for 68.7% 
of hypertensive patients taking medication. Of these, 225 (52.6%) took 
one medication with 171 (76.0%) controlled, 145 (33.87%) took two 
medications and 98 (67.6%) were controlled, 42 (9.8%) took three 
antihypertensive drugs with 30 (71.4%) controlled, 10 (2.3%) took four 
different medications with 100% control rate, and 6 (1.42%) took five 
or more medications achieving BP control in 4 (66.7%). Aspirin was the 
second most used drug among hypertensive patients (33.5%), followed 
by statins (25.5%). 
 
A polynomic (two degrees) model of the association between age and 
mean BP from all three readings, including patients not receiving 
pharmacological treatment, (Figure 3) showed an ascending linear trend 
for SBP in women, and an inverted U shape for DBP, with the largest 
increment in BP between 65 and 75 years of age. Meanwhile, both 
curves showed an inverted U shape for men with the highest BP levels 
between 50 and 60 years for SBP, and between 45 and 55 years for DBP. 
Men had an SBP higher than women up until 73 years, at which point 
trends are inverted. The same phenomenon was also observed for DBP 
at age 72. 
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Table 2. Mean Blood Pressure by State, before and after standardization by age and sex. 
 
State n (%) 
SBP (mmHg) DBP (mmHg) 
Standardized by age and sex 
SBP (mmHg) DBP (mmHg) 
Mean SD Mean SD Mean SD Mean SD 
Aguascalientes 154 (6.1) 114.66 12.13 73.08 9.48 110.75 12.13 70.56 9.48 
Baja California 160 (6.3) 121.64 14.07 75.64 11.06 119.57 14.07 74.67 11.06 
Chihuahua 176 (6.9) 120.41 11.95 79.89 10.72 118.99 11.95 78.79 10.72 
Chiapas 328 (12.9) 119.89 11.58 76.91 8.26 118.78 11.58 76.97 8.26 
Coahuila 104 (4.1) 129.93 20.42 84.92 11.98 130.13 20.42 85.20 11.98 
Durango 152 (6.0) 122.16 14.82 82.09 22.54 118.62 14.82 80.88 22.54 
Guanajuato 151 (5.9) 114.71 7.99 75.44 5.06 114.21 7.99 75.34 5.06 
México 167 (6.6) 119.65 14.58 78.52 10.71 118.27 14.58 77.99 10.71 
Nayarit 178 (7.0) 120.04 11.91 79.55 9.33 118.64 11.91 78.88 9.33 
Nuevo León 28 (1.1) 122.75 6.94 77.14 3.20 122.04 6.94 76.95 3.20 
Puebla 327 (12.8) 124.43 14.36 76.64 8.05 123.13 14.36 76.33 8.05 
San Luis Potosí 25 (1.0) 123.47 15.37 80.51 11.28 114.85 15.37 76.58 11.28 
Sonora 304 (11.9) 122.71 14.60 80.93 12.02 120.82 14.60 79.73 12.02 
Veracruz 240 (9.4) 121.85 15.54 76.13 11.42 120.81 15.54 76.04 11.42 
Zacatecas 51 (2.0) 123.15 14.82 81.46 9.73 122.52 14.82 80.86 9.73 
 
 
The control group was composed of 704 participants; their mean BP 
including all three readings was 114.52 mmHg for SBP and 75.14 mmHg 
for DBP. Analyzing for possible factors attributable to changes in BP, all 
variables except pregnancy, which decreased DBP by 1.5 mmHg, were 
associated with an increased mean difference (MD) in BP, as can be 
seen in Figure 4. Factors with the most influence over SBP were history 
of MI (13.41 mmHg), diabetes (12.80 mmHg), and stroke (12.11 mmHg). 
The highest increase in DBP was observed in participants with a history 
of stroke (6.64 mmHg), diabetes (4.59 mmHg) and MI (3.47 mmHg). 
Tobacco smoking was shown to increase SBP by 7.25 mmHg and DBP 
by 3.37 mmHg, whereas alcohol drinking increased 4.06 and 7.06 mmHg 
for SBP and 2.21 and 2.50 mmHg for DBP in those who drank one to 
three times per month and at least once a week, respectively. Aside 
from medical history, fasting at the time of screening was the condition 
associated with the highest increase in SBP (10.36 mmHg); DBP only 
increased by 3.01 mmHg. 
 
A proportional increase in BP and BMI was observed, with obese 
participants having an additional 13.54 mmHg in SBP and 8.11 mmHg in 
DBP. On the contrary, those considered underweight had a decrease of 
0.43 mmHg in SBP and 4.92 mmHg in DBP compared with those in the 
control group, as shown in Figure 5. 
 
Figure 3. Change in Blood Pressure with Age and Sex from Linear Polynomic Model. 
 
Figure 4. Change in Mean Systolic and Diastolic Blood Pressure Compared to 




Comparing mean heart rate from all three BP readings, a similar 
phenomenon from that observed with BMI emerges, where the greater 
the heart rate, the higher the increase in BP. An increase of 16.68 mmHg 
in SBP and 10.79 mmHg in DBP were seen with heart rates ≥100 bpm. 
Meanwhile, when the heart rate is <60 bpm, DDB descends 0.73 mmHg 























Systolic Blood Pressure 





History of MI SBP 







Alcohol: 1-3 per month SBP 
Alcohol: 1-3 per month DBP 
Alcohol: 1 or more 
per week SBP 
Alcohol: 1 or more 




Yamamoto-Moreno JA, et al Hypertension Awareness, Treatment and Control in Mexico: An Opportunistic 
Medical Student-led Blood Pressure Screening Campaign – A Cross-Sectional Study
 
 
Int J Med Students   •   2020  |  Sep-Dec  |  Vol  8  |  Issue 3 
                             DOI 10.5195/ijms.2020.639  |  ijms.info The International Journal of Medical Students 267
 
 
Table 3. Mean Blood Pressure by Social Gap Index, Before and After Standardization by Age and Sex. 
 
Social Gap Index n (%) 
SBP (mmHg) DBP (mmHg) 
Standardized by age and sex 
SBP (mmHg) DBP (mmHg) 
Mean SD Mean SD Mean SD Mean SD 
Very lowa 286 (11.2) 118.90 17.81 76.51 12.16 122.84 17.81 79.01 12.16 
Lowb 858 (33.7) 119.82 14.02 78.32 11.34 121.14 14.02 78.64 11.34 
Mediumc 481 (18.9) 117.24 12.07 78.40 14.31 120.07 12.07 80.98 14.31 
Highd 352 (13.8) 122.55 14.57 76.34 8.30 124.14 14.57 82.29 8.30 
Very highe 568 (22.3) 119.63 13.42 76.58 9.73 120.89 13.42 80.64 9.73 
 
Legend: a Includes Aguascalientes, Coahuila and Nuevo León; b Includes Baja California, Chihuahua, México, Sonora and Zacatecas; c Includes Durango, Guanajuato and Nayarit; 
d Includes Puebla and San Luis Potosí; e Includes Chiapas and Veracruz 
 
 
Table 4. Mean Blood Pressure by Social Gap Index, Before and After Standardization by Age and Sex. 
 
 SBP (mmHg) DBP (mmHg)   





1 120.43 15.29 77.50 11.23 546 21.45 
2 119.21 14.67 77.37 18.24 514 20.20 
3 119.05 14.15 77.26 11.37 455 17.88 
Mean of 1 and 2 119.82 14.50 77.43 12.74 450 17.68 
Mean of 2 and 3 119.13 14.12 77.31 12.73 422 16.58 
Mean of 1, 2 and 3 119.56 14.18 77.38 11.40 414 16.27 
 
 
Figure 5. Change in Mean Systolic and Diastolic Blood Pressure Compared to 





In this study of over 2,500 adults in Mexico, it was observed that 24.5% 
were hypertensive, similar to the 25.5% reported by the ENSANUT 2016 
study and lower compared to 73.0% reported by the MMM 2019 study 
for the Americas region.6,10 Of those with hypertension, 18.0% were 
unaware they might have it, 21.0% were uncontrolled hypertensives 
and 61.0% had BP values <140/90 mmHg, therefore were considered to 
be well-controlled patients for this study. These numbers are far more 
optimistic than those reported by previous studies with only 45.6% and 
37.1% of controlled subjects and 40.0% and 53.5% of unaware patients 
in national and global surveys, respectively.10,12 This could be explained 
by the opportunistic nature of this study. Also, through this campaign, 
hypertension awareness was raised in only 113 individuals across 
Mexico. 
Figure 6. Change of Systolic and Diastolic Blood Pressure Compared to Non-




According to Ríos-Blancas et al.,13 low and very low SGI states have a 
higher probability of receiving a pharmacological treatment than states 
with a high and very high SGI, which accounts for three in four cases 
receiving treatment, but less than a third of these achieving BP control. 
This is consistent with the findings in this study, which showcased that 
states with a high marginalization were found to be the largest 
contributor to the pool of uncontrolled cases (33%). On the other hand, 
the largest proportion of hypertension unawareness was observed at 
very low SGI states (34%), almost doubling the national figure. In 
contrast, states with medium (67%), low, and very high SGI (66%) had 
the highest proportion of controlled hypertensives. Possible 
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to their perceived value among populations that are not accustomed to 
receiving medical treatment, which improves compliance in these groups. 
 
More than half of the participants taking antihypertensive agents were 
on a single medication, achieving blood pressure control in almost 8 in 
10 patients. This is the largest proportion compared with the use of 
additional medication in this study, which contrasts with the findings 
of the MMM 20196 where almost 4 in 10 patients on a single agent were 
uncontrolled. However, these findings do not dispute the 
recommendations to initiate pharmacological treatment with two 
agents14,15 as a 67.6% controlled rate was observed with this regimen. 
The questionnaire used in this study did not allow to collect data about 
specific types of antihypertensive drugs used by participants, only the 
number of pharmacologic agents they used. On the other hand, aspirin 
was taken by a large proportion of participants, 33.5% of hypertensives 
and 12.8% of non-hypertensives, which goes against the latest 
recommendations about minimizing the routine usage of aspirin for the 
primary prevention of CVD because of lack of net benefit.16 
 
A strong association consistent with previous publications was 
observed between BP and several known risk factors such as smoking 
and alcohol intake,17,18 with the latter showing a dose-response effect 
with a greater increase in BP in heavy drinkers similar to what has been 
described by other authors.19 A higher BMI was consistently related to 
a higher BP, although participants considered to have obesity in this 
study had a much higher increase in BP (SBP 13 mmHg and DBP 8 
mmHg) compared to that reported by previous studies.6,19,20 This is a 
serious concern because Mexico has one of the highest rates of obesity 
worldwide, and these are continuing to rise,21 therefore a similar trend 
in hypertension could be expected if no further actions are taken. 
 
On the other hand, subjects with a history of stroke and MI showcased 
a surplus in BP compared to the control group with an increase of 12 
and 13 mmHg in SBP, respectively. A similar phenomenon was also 
observed in people with diabetes. These findings could suggest that 
patients with a history of stroke and MI in this population were not 
adequately controlled, even though hypertension is the most important 
factor for stroke recurrence.22 However, a J-curve phenomenon has been 
described23 in which a permissible BP target should be achieved to 
prevent the overly strict controlling of BP increasing the risk of adverse 
outcomes. On the contrary, evidence suggests that prompt, long-term 
BP control is imperative to improve secondary prevention of MI.24 Thus, 
further studies are needed to explore this topic, specifically in the 
Mexican population. 
 
Risk of ascertainment and selection bias were inherent to the design 
because participants presented voluntarily at screening sites; therefore, 
people worried about their BP were more likely to participate. Thus, 
prevalence should not be inferred. It is worth noting that standardized 
by age and sex mean BP was within the normal range in all states. 
Coahuila had the highest mean BP with 130/85 mmHg, whereas 
Aguascalientes had the lowest with 110/70 mmHg. As an opportunistic 
campaign and cross-sectional study using convenience sampling, it 
could be expected that a higher proportion of health-conscious 
individuals (either well-controlled hypertensive patients or otherwise 
healthy people) took part in the study, which could explain atypical 
results. Any generalization about these results should be made 
cautiously. 
 
Despite efforts to provide training on standardized BP readings to 
volunteers, differences in screening locations, and the usage of 
different equipment account for some degree of error in measurements. 
Although data about the devices used to measure BP was collected, the 
heterogeneity in reporting and the vast array of brands and models did 
not facilitate further analysis. However, as reported by Varshney et al.,25 
there is no significant difference in BP readings using automated and 
auscultatory methods to determine SBP in the context of a community-
based screening program, but DBP might differ between methods. 
Likewise, the main researchers did not have control over the number 
of students working at screening sites, which further limits the accuracy 
of measurements. 
 
Most current guidelines recommend using ambulatory or home BP 
measurements,14,15 this approach was not cost-effective for this study, 
and the diagnosis of hypertension was based on a single set of 
readings. While this might not be ideal, spaced serial measurements 
including three BP readings provided a means to mitigate the impact 
of atypical values, errors in measurement or factors related to the 
patient such as white coat syndrome. On the other hand, at least one 
BP reading was missing for 31.4% of participants, which could 
significantly affect the statistical analysis and lead to an over-diagnosis 
of hypertension. Using multiple imputation, it was possible to mitigate 
that error by estimating mean second and third BP readings from a 
single measurement with minimal error in data distribution models. 
Nevertheless, the interpretation of results from this imputed data 
should be taken carefully. 
 
A questionnaire was used to obtain the medical history of participants. 
This limits our ability to explore other comorbidities not included in the 
original questionnaire, but it does not mean that other associations 
with hypertension (apart from diabetes, MI, and stroke) could not be 
found. Also, this questionnaire asked participants about the usage of 
pharmacological agents prescribed by a physician for BP control, thus, 
differences in the accuracy of recollection could have led to a recall 
bias involving the number of drugs taken by participants. 
 
To our knowledge, this is currently the only medical student-led 
campaign to raise hypertension awareness at a national level in Mexico. 
It was observed that a significant proportion of the study population 
was unaware of having hypertension, especially in states with a lower 
level of marginalization and considered to be more developed. In 
contrast, a larger number of subjects within BP control targets were 
found in more marginalized, less developed regions. 
 
Most uncontrolled hypertensive patients in Mexico belong to 
marginalized states. These results could inform state legislative policy 
to help bridge these healthcare gaps by improving hypertension 
detection, especially among those who do not partake in regular health 
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